Unraveling GRIA1 neurodevelopmental disorders: Lessons learned from the p.( Ala636Thr ) variant
Clinical Genetics · 2024-10 · 106 (4) · 427-436
DOI: 10.1111/cge.14577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 18.06.2024. Verfasst von Nicolai Kohring Tvergaard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Kennedy Center, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Receptors, AMPA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Ionotropic glutamate receptors (iGluRs), specifically α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptors (AMPARs), play a crucial role in orchestrating excitatory neurotransmission in the brain. AMPARs are intricate assemblies of subunits encoded by four paralogous genes: GRIA1‐4 . Functional studies have established that rare GRIA variants can alter AMPAR currents leading to a loss‐ or gain‐of‐function. Patients affected by rare heterozygous GRIA variants tend to have family specific variants and only few recurrent variants have been reported. We deep‐phenotyped a cohort comprising eight unrelated children and adults, harboring a recurrent and well‐established disease‐causing GRIA1 variant (NM_001114183.1: c.1906G>A, p.(Ala636Thr)). Recurrent symptoms included motor and/or language delay, mild–severe intellectual disability, behavioral and psychiatric comorbidities, hypotonia and epilepsy. We also report challenges in social skills, autonomy, living and work situation, and occupational levels. Furthermore, we compared their clinical manifestations in relation to those documented in patients presenting with rare heterozygous variants at analogous positions within paralogous genes. This study provides unprecedented details on the neurodevelopmental outcomes, cognitive abilities, seizure profiles, and behavioral abnormalities associated with p.(Ala636Thr) refining and broadening the clinical phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Genetics, Kennedy Center, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Molecular and Medical Genetics, Tbilisi State Medical University, Tbilisi, Georgia.
- Department of Pediatrics, Givi Zhvania Pediatric Academic Clinic, Tbilisi State Medical University, Tbilisi, Georgia.
- Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.
- Department of Pediatric Neurology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Zeynep Tümer
Zitieren
APA
Tvergaard, N. K., Tkemaladze, T., Stödberg, T., Kvarnung, M., Tatton-Brown, K., Baralle, D., Tümer, Z., & Bayat, A. (2024). Unraveling GRIA1 neurodevelopmental disorders: Lessons learned from the p.( Ala636Thr ) variant. Clinical Genetics, 106(4), 427-436. https://doi.org/10.1111/cge.14577
Vancouver
Tvergaard NK, Tkemaladze T, Stödberg T, Kvarnung M, Tatton-Brown K, Baralle D, et al. Unraveling GRIA1 neurodevelopmental disorders: Lessons learned from the p.( Ala636Thr ) variant. Clinical Genetics. 2024;106(4):427-436. doi:10.1111/cge.14577
BibTeX
@article{Tvergaard2024,
author = {Tvergaard, Nicolai Kohring and Tkemaladze, Tinatin and Stödberg, Tommy and Kvarnung, Malin and Tatton-Brown, Katrina and Baralle, Diana and Tümer, Zeynep and Bayat, Allan},
title = {Unraveling GRIA1 neurodevelopmental disorders: Lessons learned from the p.( Ala636Thr ) variant},
journal = {Clinical Genetics},
year = {2024},
volume = {106},
number = {4},
pages = {427--436},
doi = {10.1111/cge.14577}
}
EUVIMED